Jiangsu Jibeier Pharmaceutical Co Ltd (688566) - Total Liabilities

Latest as of March 2026: CN¥222.75 Million CNY ≈ $32.60 Million USD

Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has total liabilities worth CN¥222.75 Million CNY (≈ $32.60 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jiangsu Jibeier Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688566 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Vishay Precision Group Inc NYSE:VPG	USA	$124.52 Million
Siantar Top Tbk JK:STTP	Indonesia	Rp651.07 Billion
Energy Vault Holdings Inc NYSE:NRGV	USA	$244.26 Million
Beijing Fengshangshiji Culture Medi SHE:300860	China	CN¥232.78 Million
Bangkok Chain Hospital Public Company Limited BK:BCH	Thailand	฿3.28 Billion
Yuanli Chemical Group Co Ltd SHG:603217	China	CN¥1.55 Billion
GHT Co Ltd Class A SHE:300711	China	CN¥481.99 Million
Anbio Biotechnology Class A Ordinary Shares NASDAQ:NNNN	USA	$87.84K

Liability Composition Analysis (2016–2025)

This chart breaks down Jiangsu Jibeier Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Jiangsu Jibeier Pharmaceutical Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Jibeier Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual total liabilities of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥267.47 Million ≈ $39.14 Million	-2.27%
2024-12-31	CN¥273.68 Million ≈ $40.05 Million	-8.55%
2023-12-31	CN¥299.25 Million ≈ $43.79 Million	+10.73%
2022-12-31	CN¥270.24 Million ≈ $39.55 Million	+28.45%
2021-12-31	CN¥210.40 Million ≈ $30.79 Million	+23.10%
2020-12-31	CN¥170.92 Million ≈ $25.01 Million	+36.56%
2019-12-31	CN¥125.16 Million ≈ $18.31 Million	+4.02%
2018-12-31	CN¥120.32 Million ≈ $17.61 Million	+38.43%
2017-12-31	CN¥86.92 Million ≈ $12.72 Million	-26.96%
2016-12-31	CN¥118.99 Million ≈ $17.41 Million	--

About Jiangsu Jibeier Pharmaceutical Co Ltd

SHG:688566 China Drug Manufacturers - Specialty & Generic

Market Cap

$730.74 Million

CN¥4.99 Billion CNY

Market Cap Rank

#10489 Global

#2887 in China

Share Price

CN¥25.04

Change (1 day)

+3.34%

52-Week Range

CN¥23.62 - CN¥42.20

All Time High

CN¥51.60